LEE011, Letrozole, BYL719 — catalyst calendar

1 verified catalyst event(s) referencing LEE011, Letrozole, BYL719, each linked to its official source. Verified as of 2026-10-23.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02-26
in 4mo
ESTIMATED
READOUT
Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
Phase 1/2 · Breast Cancer
NVS NOVARTIS AG LEE011, Letrozole, BYL719 ClinicalTrials.gov ↗
✓ Source-checked 2026-10-23
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.